REGULARISATION OF APPOINTMENT OF MRS. NEHA SARDA AS INDEPENDENT DIRECTOR OF THE COMPANY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Limited held an Extra-Ordinary General Meeting (EGM) on May 11, 2026, where shareholders approved the regularisation of appointment of Mrs. Neha Sarda as a Non-Executive Independent Director. She was originally appointed as an Additional Director on January 3, 2026, and this appointment has now been formalised by shareholders for a term of 5 years. Mrs. Sarda is a qualified Company Secretary with expertise in corporate law, governance, and compliance. She is not related to any existing director and meets the independence criteria under Section 149(6) of the Companies Act, 2013 and SEBI LODR Regulations.
This is a routine corporate governance update confirming the formal appointment of an independent director. No material impact on stock price expected as this is standard compliance procedure.